BMD4503-1
BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 301357-76-6
- Formule: C22H19N5O3S
- Masse moléculaire:433.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
CAS No. 301357-76-6
-
Masse moléculaire 433.48
-
Formule C22H19N5O3S
-
SMILES
O=C(C)NC1=CC=C(S(=O)(NC2=NC3=C(N=C2NC4=CC=CC=C4)C=CC=C3)=O)C=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)